Form 4: Boston Scientific CEO's Trusts Engage in Stock Gift Transactions
Insider Transaction Report
Boston Scientific CEO Michael F. Mahoney's associated trusts completed gift transactions of common stock, resulting in changes to his indirect beneficial ownership.
Summary
- Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corp., reported gift transactions of common stock involving his associated trusts.
- On October 29, 2025, The Michael F. Mahoney 2 Year Qualified Annuity Trust 2023 acquired 88,197 shares of common stock via gift. Following this, 289,675 shares were indirectly beneficially owned through this trust.
- Also on October 29, 2025, The Michael F. Mahoney 2 Year Qualified Annuity Trust 2024 acquired 73,996 shares of common stock via gift. Following this, 363,671 shares were indirectly beneficially owned through this trust.
- On October 30, 2025, Michael F. Mahoney gifted 149,992 shares of common stock to The Michael F. Mahoney Term Irrevocable Trust 2025. Following this, 213,679 shares were indirectly beneficially owned through this trust.
- Following these transactions, Michael F. Mahoney's direct beneficial ownership stands at 1,476,882 shares.
Sentiment
Score: 5
Explanation: Neutral. The filing reports routine insider gift transactions for estate planning purposes, which do not reflect on the company's operational or financial performance.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compliance Disclosure | The filing reflects standard compliance with Section 16(a) of the Securities Exchange Act of 1934 regarding changes in beneficial ownership by an insider. | 10/31/2025 | Ensures transparency in insider holdings as required by regulatory standards. |
Related Party Transactions
- Michael F. Mahoney engaged in gift transactions of common stock with trusts associated with him (The Michael F. Mahoney 2 Year Qualified Annuity Trust 2023, The Michael F. Mahoney 2 Year Qualified Annuity Trust 2024, and The Michael F. Mahoney Term Irrevocable Trust 2025).
Stakeholder Impact
- Minimal impact on shareholders as these are gift transactions for estate planning, not open market sales.
- No direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 10/29/2025 | Date of gift transactions by Michael F. Mahoney's annuity trusts. |
| 10/30/2025 | Date of gift transaction by Michael F. Mahoney to an irrevocable trust. |
| 10/31/2025 | Date Form 4 was signed by Attorney-in-Fact. |
Keywords
Boston Scientific, BSX, Michael F. Mahoney, Form 4, insider transaction, stock gift, beneficial ownership, corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.